While these medications are effective for managing type 2 diabetes and promoting weight loss, many people are surprised to notice changes in their hair health during treatment
Veerichetty and Saravanabavan, 2023)
With semaglutide, liraglutide, dulaglutide, and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 agonist tirzepatide achieving global blockbuster status, more than 50 million patients worldwide currently receive GLP-1 RA therapy [1]
Safety Considerations When Using Allulose Allulose is generally recognised as well-tolerated when consumed in moderate amounts, though several safety considerations warrant attention
How Should IGF-1 LR3 Be Reconstituted and Stored
Not a magic pill Research on GLP-1s has shown that weight regain is very common once the medication has been stopped if the person hasnt implemented sustainable lifestyle changes